Furthermore, analysis of the TCGA BRCA breast cancer cohort revealed a significantly higher expression level of LY6E in breast tumor patients compared to healthy individuals, especially in basal subtype of BRCA. This evidence concerns the gene LY6E and breast neoplasm.